Senti Biosciences Holdings
SNTI
20 hedge funds and large institutions have $9.17M invested in Senti Biosciences Holdings in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 10 closing their positions.
121% more capital invested
Capital invested by funds: $4.15M → $9.17M (+$5.03M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
0.13% less ownership
Funds ownership: 2.4% → 2.27% (-0.13%)
26% less funds holding
Funds holding: 27 → 20 (-7)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.2K |
| 2 |
HF
HRT Financial
New York
|
+$4.05K |
| 3 |
Morgan Stanley
New York
|
+$1.23K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$188 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Triatomic Management
Palo Alto,
California
|
-$95.6K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$54.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$29.8K |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$14.6K |
| 5 |
Renaissance Technologies
New York
|
-$9K |
SNTI Hedge Fund Activity: Q2 2024 in Review
20 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q2 2024, worth a combined $9.17M — up 121% from $4.15M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of SNTI and 3 opened new positions — a net loss of 7 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $10.2K. The largest seller was Triatomic Management, cutting an estimated $95.6K.
- 20 institutional investors held Senti Biosciences Holdings (SNTI) as of Q2 2024, down from 27 in Q1 2024.
- Funds reported $9.17M of Senti Biosciences Holdings stock for Q2 2024, up 121% quarter-over-quarter.
- 3 funds opened new Senti Biosciences Holdings positions in Q2 2024 and 10 closed out, a net change of -7 holders.
- The largest Senti Biosciences Holdings buyer in Q2 2024 was Susquehanna International Group, an estimated $10.2K added.
- The largest Senti Biosciences Holdings seller in Q2 2024 was Triatomic Management, an estimated $95.6K sold.
Based on aggregated 13F filings for Q2 2024.